(Reuters) -Bavarian Nordic said on Thursday it has signed an agreement with the United Nations Children's Fund (UNICEF) for ...

Bavarian Nordic has received a $63m US contract to produce bulk product and final freeze-dried doses of the JYNNEOS ...

Bavarian Nordic has received an order worth $63 million from the U.S. government to produce additional bulk product and the ...

Bavarian Nordic A/S, one of a few companies with an approved mpox vaccine, is upgrading its financial guidance after securing more orders for its jab as an outbreak rages in Africa.

The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the ...

Research shows that the effectiveness of Bavarian Nordic’s Mpox vaccine drops to undetectable levels after 6-12 months.

The WHO has faced criticism for moving too slowly on mpox vaccines. Bavarian Nordic's vaccine has been used worldwide since 2022, after U.S. and European regulators backed it for use against a ...

Bavarian Nordic has received a $63 million order from BARDA to produce Jynneos mpox vaccine doses. The contract will support ...

Gavi, the global vaccine group, announced it will purchase 500,000 doses of Bavarian Nordic’s mpox vaccine. This marks Gavi’s ...

Bavarian Nordic has secured a $63 million contract from the U.S. government to produce the Jynneos vaccine for mpox and ...

The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, ...

First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September 26, 2024 - Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with ...